Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [ 11 C]RS-016 targeting CB2 in atherosclerosis-Reference-Cited by-同舟云学术

Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [ 11 C]RS-016 targeting CB2 in atherosclerosis

Published:2017-04 Issue: Volume:47 Page:31-43
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Meletta Romana,Slavik Roger,Mu Linjing,Rancic Zoran,Borel Nicole,Schibli Roger,Ametamey Simon M.,Krämer Stefanie D.,Müller Herde Adrienne

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference68 articles.

1. The immune system in atherosclerosis;Hansson;Nat Immunol,2011

2. New risk factors for atherosclerosis and patient risk assessment;Fruchart;Circulation,2004

3. Mechanisms of plaque formation and rupture;Bentzon;Circ Res,2014

4. Novel candidate genes in unstable areas of human atherosclerotic plaques;Papaspyridonos;Arterioscler Thromb Vasc Biol,2006

5. Gene Expression in Macrophage-Rich Inflammatory Cell Infiltrates in Human Atherosclerotic Lesions as Studied by Laser Microdissection and DNA Array

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissecting the role of cannabinoids in vascular health and disease;Journal of Cellular Physiology;2024-07-10

2. Patent review of cannabinoid receptor type 2 (CB ₂ R) modulators (2016-present);Expert Opinion on Therapeutic Patents;2024-07-02

3. Evaluation of [¹⁸F]RoSMA-18-d₆ as a CB2 PET Radioligand in Nonhuman Primates;ACS Chemical Neuroscience;2023-10-03

4. Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity;Biomedicines;2023-06-08

5. Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease;Frontiers in Aging Neuroscience;2022-09-30